Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Alloy

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Alloy head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 274 · Grade C

Alloy

Visit Alloy Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Alloy a bad call — it's best for readers seeking midlife-focused physician care who can budget for both the care fee and the selected prescription. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
76
Transparency
90
32
Access Breadth
93
62
Clinical Oversight
92
87
Track Record
88
78
CoreAge RxBrief Score 94 · 64Alloy

Price, coverage & the tracker

CoreAge RxAlloy
Brief Score94/100 (A)64/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Medication from $70 + $99/month care

Compounded injection, one-month medication supply; complete selected-prescription charge requires confirmation.

Care cancellation seven days before period end; shipment pause/cancel five business days before processing. First-care-charge promotion is separate.

Compounded program unavailable in AL, AR, CA, NV, LA, MS and D.C.; branded eligibility differs.

Full price details

Compounded semaglutide offered; complete selected-prescription quote unknown; medication from $70 for a one-month supply plus required $99/month Weight Care; branded options have separate prices

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Medication from $100 + $99/month care

Compounded injection, one-month medication supply; branded products have separate medication prices.

Care and consultation charges nonrefundable; refund requests for the first shipment of each product have their own thirty-day window.

Compounded program unavailable in AL, AR, CA, NV, LA, MS and D.C.; branded eligibility differs.

Full price details

Compounded tirzepatide offered; complete selected-prescription quote unknown; medication from $100 for a one-month supply plus required $99/month Weight Care; branded options have separate prices

CoverageUS only; restrictions by state, confirmed at intakeCompounded semaglutide and tirzepatide are not available in Alabama, Arkansas, California, Nevada, Louisiana, Mississippi or D.C.; branded programs have separate eligibility.
Brand-name accessNot confirmedNamed Wegovy, Zepbound and Foundayo programs are advertised; drug costs are separate from care and exact eligibility requires review.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Alloy: Weight Care is $99/month plus medication: compounded semaglutide from $70 or tirzepatide from $100 for a one-month supply. Confirm the combined selected quote and both cancellation deadlines.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.